1For more information on these measures, refer to the Use of Non-GAAP Measures and Definitions schedules. |
2attributable to Cardinal Health, Inc. |
3Reflects the estimated net transitional benefit from the re-measurement of our deferred tax assets and liabilities partially offset by the one-time repatriation tax on cash and earnings of foreign subsidiaries. We have not yet completed our analysis of the impact of the Tax Act and, as such, these amounts are provisional estimates and we may record additional provisional amounts or adjustments to the provisional amounts in future periods. |
4Non-GAAP EPS for the three and six months ended December 31, 2017 includes a $0.20 benefit from applying a lower federal tax rate to our year-to-date U.S. pre-tax non-GAAP earnings. Excluding this benefit, non-GAAP EPS would have been $1.31 and $2.40 for the three and six months ended December 31, 2017, respectively. |